Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000939767-25-000128
Filing Date
2025-11-04
Accepted
2025-11-04 16:30:07
Documents
80
Period of Report
2025-10-03

Document Format Files

Seq Description Document Type Size
1 10-Q exel-20251003.htm   iXBRL 10-Q 1516650
2 EX-31.1 exel20250930exhibit31110-q.htm EX-31.1 9471
3 EX-31.2 exel20250930exhibit31210-q.htm EX-31.2 9451
4 EX-32.1 exel20250930exhibit32110-q.htm EX-32.1 7251
10 exel-20251003_g1.jpg GRAPHIC 55431
  Complete submission text file 0000939767-25-000128.txt   7851863

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20251003.xsd EX-101.SCH 52433
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT exel-20251003_cal.xml EX-101.CAL 75640
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT exel-20251003_def.xml EX-101.DEF 239838
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20251003_lab.xml EX-101.LAB 617422
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20251003_pre.xml EX-101.PRE 432287
82 EXTRACTED XBRL INSTANCE DOCUMENT exel-20251003_htm.xml XML 1262255
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
Type: 10-Q | Act: 34 | File No.: 000-30235 | Film No.: 251449623
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)